D. Croom

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
D K Croom, Dallas K Croom, Dallas Croom, Dallas K. Croom, D Croom
Publication record
20 papers · 837 citations · H-index 15

PAPERS

Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 agonists.
201219 citationsauthor #10
Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.
2012103 citationsauthor #8
GPR119 activation integrates the secretion of gastrointestinal peptides and islet hormones
20100 citationsauthor #2
2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV.
200523 citationsauthor #9
Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments.
200488 citationsauthor #2
Structure-based design of potent retinoid X receptor alpha agonists.
200452 citationsauthor #14
1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.
200124 citationsauthor #4
Dietary fat alters HIV protease inhibitor-induced metabolic changes in mice.
200028 citationsauthor #2
HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis
2000149 citationsauthor #2
4-Substituted Uridine 5′-Triphosphates as Agonists of the P2Y2 Purinergic Receptor
199710 citationsauthor #5
Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
199768 citationsauthor #4
Discovery of 1,5‐Benzodiazepines with Peripheral Cholecystokinin (CCK‐ A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent.
19974 citationsauthor #4
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituent.
199642 citationsauthor #4
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger".
199688 citationsauthor #6
3-(2-(N-Phenylacetamide))-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists.
19965 citationsauthor #7
3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents.
199622 citationsauthor #4
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonists.
199624 citationsauthor #7
Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin.
199631 citationsauthor #3
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
199511 citationsauthor #4
Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.
199548 citationsauthor #3

TIMELINE

1995 59 citations

1996 212 citations

1997 82 citations

2000 177 citations

2001 24 citations

2004 140 citations

2005 23 citations

2010 0 citations

2012 122 citations

D. Croom

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT